News by subject: Conference

Colbeck Capital Management, a leading middle-market private credit firm focused on strategic lending, is pleased to share that Evan Buckwalter from the firm's Business Development group will be attending the Smart Business Dealmakers Conference this...

Newegg Marketplace, a division of Newegg Commerce, Inc. , a leading global e-commerce company specializing in computers and consumer electronics, today announced the company will exhibit at the Retail Innovation Conference and Expo 2024 (RICE), June...

Sila Realty Trust, Inc. (the "Company"), a net lease real estate investment trust with a strategic focus on investing in the significant, growing, and resilient healthcare sector of the U.S. economy, announced that President and Chief Executive...

Amprius Technologies, Inc. ("Amprius" or the "Company") , a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced its schedule for June appearances and activities. Defense Power and Energy Conference...

Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologic intended to enhance regulatory T cell (Treg) function, announces the acceptance of a peer-reviewed manuscript titled, "A Phase 1...

To help accelerate the promise of precision medicine, Thermo Fisher Scientific today unveiled its new solutions accelerating research workflows at the annual American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied...

GSK plc (LSE/NYSE: GSK) today announced updated, longer-term results from the phase II supported collaborative study with Memorial Sloan Kettering Cancer Center (MSK) evaluating Jemperli (dostarlimab-gxly) as a first-line treatment?as an alternative...

2024 BIO International Convention?YourChoice Therapeutics, Inc., pioneering hormone-free family planning products, has completed its first-in-human clinical study for YCT-529, designed to be the first hormone-free birth control pill for men....

Bristol Myers Squibb today announced results from three updated analyses from the CheckMate -77T, CheckMate -816, and CheckMate -9LA studies supporting Opdivo® (nivolumab) and Opdivo-based combinations in early stage and advanced non-small cell lung...

Wag! (Wag! Group Co., Nasdaq: PET), which strives to be the number one platform to solve the service, product, and wellness needs of the modern U.S. pet household, today announced its participation in the following events: Lake Street Pet Day....

Ecolab today announced that its Purolite resin business, together with Repligen Corporation , a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of Purolite's DurA Cycle, a protein A...

Novocure today announced the presentation of clinical data from the phase 3 METIS trial, which investigated the use of Tumor Treating Fields (TTFields) therapy in the treatment of brain metastases from non-small cell lung cancer (NSCLC). These data...

Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced updated data from the ongoing Phase 1 first-in-human, dose-escalation study of OBX-115, a novel engineered...

Charles River Laboratories International, Inc. announced today that it will present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4th, at 10:00 a.m. CT (11:00 a.m. ET), and at the Jefferies Global Healthcare Conference on...

Aatru Medical, LLC announced that it was awarded 1st Place in Oral Abstracts at the 2024 Spring symposium hosted by the Society for Advanced Wound Care (SAWC). Aatru's Oral Abstract detailed the clinical evaluation of their new, single-use negative...

Natera, Inc. , a global leader in cell-free DNA and genetic testing, today announced that it will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024 at 7:40 a.m. PT (10:40 a.m. ET). A live webcast may be...

Easterly Government Properties, Inc. (the "Company" or "Easterly"), a fully integrated real estate investment trust focused primarily on the acquisition, development and management of Class A commercial properties leased to the U.S. Government and...

Hewlett Packard Enterprise today introduced HPE Aruba Networking Enterprise Private 5G to help customers accelerate and simplify the deployment and management of private 5G networks, providing high levels of reliable wireless coverage across large...

Sylvamo senior vice president and chief financial officer, John Sims, will participate in a fireside chat and host meetings Tuesday, June 11, during the 2024 Wells Fargo Industrials Conference in Chicago, Illinois. The fireside chat will begin at...

Fulgent Pharma, a subsidiary of Fulgent Genetics, Inc. and a leading nanobiotechnology company specializing in innovative cancer therapeutics, today announced that Phase 1 clinical data on its lead therapeutic development candidate, FID-007, to...

Independence Realty Trust, Inc. ("IRT") today announced that Scott Schaeffer, Chairman and Chief Executive Officer, Jim Sebra, Chief Financial Officer and Jason Delozier, Chief Accounting Officer will be meeting with investors and analysts at...

VeeamON ? ExaGrid®, the industry's only Tiered Backup Storage solution with Retention Time-Lock that includes a non-network-facing tier (creating a tiered air gap), delayed deletes and immutability for ransomware recovery, announced today during the...

Arcos Dorados Holdings, Inc. ("Arcos Dorados" or the "Company"), Latin America's largest restaurant chain and the world's largest independent McDonald's franchisee, today announced its participation in the following investor event: Bradesco BBI...

At the 72nd ASMS meeting, Bruker Corporation launches the new top-of-the-line timsTOF Ultra 2 system with significantly further enhanced sensitivity for deep profiling of small cells, subcellular organelles, as well as increased sample loading...

Turing Medical, the leader in precision targeting for neuromodulation therapies, today announced the launch of Bullsai, its new brain mapping and targeting solution, at the American Society for Stereotactic and Functional Neurosurgery (ASSFN)...

Innoviva, Inc. ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic...

Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patients' lives by developing and commercializing innovative products across a range of therapies, today announced it presented a post-hoc analysis...

Spruce Biosciences, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine disorders with significant unmet medical need, presented results from its Phase 2 POWER study of tildacerfont, a...

Bicycle Therapeutics plc , a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in the following investor...

IDRx, Inc., a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment with purpose-built precision therapies, today announced updated preliminary clinical data from the Phase 1 portion of the company's ongoing StrateGIST 1...

Takeda (TSE: 4502/NYSE:TAK) will present today positive results from its Phase 2b trial of TAK-861 in narcolepsy type 1 (NT1) as late-breaking data presentations at SLEEP 2024, the 38th annual meeting of the American Academy of Sleep Medicine and the...

KalVista Pharmaceuticals, Inc. , today announced that it presented real-world data from US patient surveys that assessed the experience of HAE patients using injectable on-demand treatments at the European Academy of Allergy and Clinical Immunology...

Genesis Energy, L.P. announced today that it will host investor meetings at the following conferences: 2024 RBC Capital Markets Global Energy, Power & Infrastructure Conference in New York City on June 4-5, 2024 2024 BofA Securities Energy...

Zura Bio Limited ("Zura Bio"), a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today announced it will present data from its tibulizumab (ZB-106) program exploring the clinical...

Diakonos Oncology Corp., a clinical-stage immuno-oncology company, announced today that Chief Financial Officer and Head Of Business Development Anthony Baldor will give a company presentation at the 2024 BIO International Convention June 3 ? 6, 2024...

Renowned globally for its research and development capabilities, GIGABYTE Technology will exhibit its products and solutions at COMPUTEX from June 4 to June 7 under the theme "ACCEVOLUTION," acclaiming the new era of accelerated-computing and time of...

Invicara will unveil digitaltwin-factory, an open-source program, at the Digital Construction Week in ExCeL London, 5th & 6th June. Enterprise innovation teams, and software solution providers can now join the digitaltwin-factory community, access...

During 3-5 June, Igloo Coolers will showcase the ICF electric compressor cooler series and IE thermoelectric cooler collection for the first time in the Europe, Middle East and Africa (EMEA) market at Outdoor by ISPO, exhibition area A3 Booth 315....

Discover Global Network®, a leading global payment network, released the first portion of the 2024 Payment State of the Union (PSOU), one of the most comprehensive studies of its kind in the industry, providing global perspectives from merchants and...

Other World Computing ? the leading solution provider of computer hardware, accessories, and software that bring artistic expression and the digital world together for creative professionals and consumers of technology ? today announced at the...

A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, London, used an ultra-sensitive liquid biopsy to...

Positive results from the LAURA Phase III trial showed AstraZeneca's TAGRISSO® (osimertinib) demonstrated a statistically significant and highly clinically meaningful improvement in progression-free survival (PFS) for patients with unresectable,...

Puma Biotechnology, Inc. , a biopharmaceutical company, announced the presentation of biomarker findings from a Phase II randomized clinical trial of alisertib alone vs. alisertib + fulvestrant for the treatment of patients with endocrine and CDK4/6...

Gilead Sciences, Inc. and Arcus Biosciences, Inc. today announced new data from Cohort B of ARC-9, a Phase 1b/2 study evaluating the safety and efficacy of etrumadenant, a dual A2a/b adenosine receptor antagonist, plus anti-PD-1 monoclonal antibody...

ASCO Annual Meeting ? Massive Bio, a renowned leader in AI-driven oncology solutions and Mika Health, the premier oncology digital therapeutic platform, today announced a partnership to significantly expand patient access to psycho oncology services,...

Detailed positive results from the DESTINY-Breast06 phase 3 trial showed that ENHERTU® (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to standard of...

Detailed positive results from the DESTINY-Breast06 Phase III trial showed that ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , today announced the presentation of seven studies from its long-acting injectable (LAI) schizophrenia research program. Presentations include data informing clinical...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , today announced new patient- and physician-reported interim results from the Phase 4 IMPACT-TD Registry study, reinforcing that TD has a wide-reaching, multidimensional...

First Ascent Biomedical announced findings from ongoing clinical studies conducted in partnership with Florida International University, examining the company's Functional Precision Medicine (FPM) platform in adult and pediatric patients with...